Novartis paused eight clinical trials of an experimental therapy targeting autoimmune and neurological disorders in late August, after three patients died.
Novartis Pauses Autoimmune Cell Therapy Studies After Deaths
Source: WSJ Technology
The Edge of the Cyber World See the latest
Novartis paused eight clinical trials of an experimental therapy targeting autoimmune and neurological disorders in late August, after three patients died.
Source: WSJ Technology